Furthermore, the study found that the loss of expression of miR-96-5p and miR-149 is observed in both tumor tissues and plasma of CRC patients, as well as in GPC1-positive exosomes derived from CRC tumor tissues and plasma, before surgical treatment. This evidence concerns the gene GPC1 and colorectal carcinoma.